JP2018090541A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018090541A5 JP2018090541A5 JP2016235957A JP2016235957A JP2018090541A5 JP 2018090541 A5 JP2018090541 A5 JP 2018090541A5 JP 2016235957 A JP2016235957 A JP 2016235957A JP 2016235957 A JP2016235957 A JP 2016235957A JP 2018090541 A5 JP2018090541 A5 JP 2018090541A5
- Authority
- JP
- Japan
- Prior art keywords
- orally disintegrating
- titanium oxide
- disintegrating tablet
- preparation
- total amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006191 orally-disintegrating tablet Substances 0.000 claims 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims 3
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 2
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 239000007888 film coating Substances 0.000 claims 1
- 238000009501 film coating Methods 0.000 claims 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- RONZAEMNMFQXRA-UHFFFAOYSA-N mirtazapine Chemical compound C1C2=CC=CN=C2N2CCN(C)CC2C2=CC=CC=C21 RONZAEMNMFQXRA-UHFFFAOYSA-N 0.000 claims 1
- 229960001785 mirtazapine Drugs 0.000 claims 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016235957A JP6601844B2 (ja) | 2016-12-05 | 2016-12-05 | 光安定性に優れたミルタザピン含有医薬製剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016235957A JP6601844B2 (ja) | 2016-12-05 | 2016-12-05 | 光安定性に優れたミルタザピン含有医薬製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018090541A JP2018090541A (ja) | 2018-06-14 |
| JP2018090541A5 true JP2018090541A5 (enExample) | 2019-02-28 |
| JP6601844B2 JP6601844B2 (ja) | 2019-11-06 |
Family
ID=62564301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016235957A Expired - Fee Related JP6601844B2 (ja) | 2016-12-05 | 2016-12-05 | 光安定性に優れたミルタザピン含有医薬製剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6601844B2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7713140B2 (ja) * | 2021-02-04 | 2025-07-25 | トーアエイヨー株式会社 | タダラフィルを含有する錠剤及びその製造方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI256309B (en) * | 1999-10-13 | 2006-06-11 | Akzo Nobel Nv | New formulation of mirtazapine |
| WO2005034921A1 (en) * | 2003-10-07 | 2005-04-21 | Andrx Pharmaceuticals Llc | Rapidly disintegrating formulation |
| JP2012001460A (ja) * | 2010-06-15 | 2012-01-05 | Ohara Yakuhin Kogyo Kk | 光過敏性薬物の安定化法 |
| JP6243265B2 (ja) * | 2014-03-20 | 2017-12-06 | 日医工株式会社 | ロスバスタチン含有医薬製剤 |
-
2016
- 2016-12-05 JP JP2016235957A patent/JP6601844B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010184203A5 (enExample) | ||
| DK2990400T3 (da) | Dicarboxylsyreforbindelse | |
| JP2019151657A5 (enExample) | ||
| JP2016509270A5 (enExample) | ||
| JP2013250478A5 (enExample) | ||
| JP2018197270A5 (enExample) | ||
| HUE045701T2 (hu) | 2-Hidroxi-1-{4-[(4-fenilfenil)karbonil]piperazin-1-il}etán-1-on származékok és rokon vegyületek mint zsírsav szintáz (FASN) inhibitorok, rák kezelésére | |
| JP2011248668A5 (enExample) | ||
| TWD171581S (zh) | Ｘ光數位攝影裝置（二） | |
| JP2020504434A5 (enExample) | ||
| JP2016540019A5 (enExample) | ||
| IL260210B2 (en) | cftr regulators and methods of using them | |
| JP2018090541A5 (enExample) | ||
| JP2017178878A5 (enExample) | ||
| JP2015114599A5 (enExample) | ||
| JP2019011379A5 (enExample) | ||
| TW201612166A (en) | Ultraviolet absorber, composition for forming a resist under layer film, and patterning process | |
| CO2022005369A2 (es) | Cristal de 3-(difluorometil)-1-metil-n-(1,1,3-trimetil-2,3-dihidro-1h-inden-4-il)-1h-pirazol-4-carboxamida | |
| JP2012229264A5 (enExample) | ||
| JP2019110342A5 (enExample) | ||
| JP2020506886A5 (enExample) | ||
| JP2017194540A5 (enExample) | ||
| Brennan | OSCAR THE CAT | |
| Stanton | The Norman Conquest | |
| MO et al. | Research on the effect of morphine hydrochloride sustained-release tablets given by different administration routes on patients with cancer pain |